Search Results - "Triozzi, P."

Refine Results
  1. 1

    Asc-Seurat: analytical single-cell Seurat-based web application by Pereira, W J, Almeida, F M, Conde, D, Balmant, K M, Triozzi, P M, Schmidt, H W, Dervinis, C, Pappas, Jr, G J, Kirst, M

    Published in BMC bioinformatics (18-11-2021)
    “…Single-cell RNA sequencing (scRNA-seq) has revolutionized the study of transcriptomes, arising as a powerful tool for discovering and characterizing cell types…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Inhibition and promotion of tumor growth with adeno-associated virus carcinoembryonic antigen vaccine and Toll-like receptor agonists by Triozzi, P L, Aldrich, W, Ponnazhagan, S

    Published in Cancer gene therapy (01-12-2011)
    “…Carcinoembryonic antigen (CEA) is a cancer vaccines’ target. Several features of recombinant adeno-associated virus (rAAV) are attractive for vaccine…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands by ALDRICH, W. A, REN, C, WHITE, A. F, ZHOU, S.-Z, KUMAR, S, JENKINS, C. B, SHAW, D. R, STRONG, T. V, TRIOZZI, P. L, PONNAZHAGAN, S

    Published in Gene therapy (01-01-2006)
    “…The potential of adeno-associated virus (AAV)-based vectors in human gene therapy is being explored for several diseases. Although sustained transgene…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Prevention of mammary tumors with a chimeric HER-2 B-cell epitope peptide vaccine by DAKAPPAGARI, N. K, DOUGLAS, D. B, TRIOZZI, P. L, STEVENS, V. C, KAUMAYA, P. T. P

    Published in Cancer research (Chicago, Ill.) (15-07-2000)
    “…Synthetic peptide vaccines targeting B-cell epitopes of the extracellular domain of the HER-2 oncoprotein were evaluated for their capacity to elicit…”
    Get full text
    Journal Article
  8. 8

    Coxsackievirus-adenovirus receptor genetically fused to anti-human CD40 scFv enhances adenoviral transduction of dendritic cells by PEREBOEV, A. V, ASIEDU, C. K, DMITRIEV, I. P, KAWAKAMI, Y, DONG, S. S, BLACKWELL, J. L, KASHENTSEVA, E. A, TRIOZZI, P. L, ALDRICH, W. A, CURIEL, D. T, THOMAS, J. M

    Published in Gene therapy (01-09-2002)
    “…A promising approach to immunotherapy involves the loading of dendritic cells (DCs) with genetic material to facilitate sustained expression of a relevant…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Genetically Targeted Adenovirus Vector Directed to CD40-Expressing Cells by Belousova, Natalya, Korokhov, Nikolay, Krendelshchikova, Valentina, Simonenko, Vera, Mikheeva, Galina, Triozzi, Pierre L, Aldrich, Wayne A, Banerjee, Papia T, Gillies, Stephen D, Curiel, David T, Krasnykh, Victor

    Published in Journal of Virology (01-11-2003)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  11. 11

    Intratumoral injection of dendritic cells derived in vitro in patients with metastatic cancer by Triozzi, Pierre L., Khurram, Reema, Aldrich, Wayne A., Walker, Michael J., Kim, Julian A., Jaynes, Sean

    Published in Cancer (15-12-2000)
    “…BACKGROUND Dendritic cells (DCs) are potent initiators of immune responses, and the infiltration of DCs into tumors may confer an improved prognosis. Whether…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    B7.1 expression by the weakly immunogenic F98 rat glioma does not enhance immunogenicity by PAUL, D. B, BARTH, R. F, YANG, W, SHEN, G.-H, KIM, J, TRIOZZI, P. L

    Published in Gene therapy (01-06-2000)
    “…Enhanced immunogenicity has been reported following transfection of a variety of immunogenic tumors with the B7.1 co-stimulatory molecule. The purpose of the…”
    Get full text
    Journal Article
  15. 15

    Phenotypic and functional differences between human dendritic cells derived in vitro from hematopoietic progenitors and from monocytes/macrophages by Triozzi, Pierre L., Aldrich, Wayne

    Published in Journal of leukocyte biology (01-05-1997)
    “…We compared dendritic cells (DC) derived from CD34+ hematopoietic progenitor cells with tumor necrosis factor α and granulocyte‐macrophage colony‐stimulating…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Effects of a beta-human chorionic gonadotropin subunit immunogen administered in aqueous solution with a novel nonionic block copolymer adjuvant in patients with advanced cancer by TRIOZZI, P. L, STEVENS, V. C, ALDRICH, W, POWELL, J, TODD, C. W, NEWMAN, M. J

    Published in Clinical cancer research (01-12-1997)
    “…The clinical and immunological effects of a vaccine consisting of CTP37, a synthetic peptide corresponding to the COOH-terminal peptide (CTP) of beta-human…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Intratumoral administration of a recombinant canarypox virus expressing interleukin 12 in patients with metastatic melanoma by Triozzi, Pierre L, Strong, Theresa V, Bucy, R Pat, Allen, Karen O, Carlisle, Ronda R, Moore, Susan E, Lobuglio, Albert F, Conry, Robert M

    Published in Human gene therapy (01-01-2005)
    “…The aim of this study was to evaluate the tolerability and activity of intratumoral administered human interleukin 12 encoded by a vector derived from the…”
    Get more information
    Journal Article
  20. 20

    189 PHASE 1 STUDY OF AN ANTI-GD3 MONOCLONAL ANTIBODY (KW-2871) IN PATIENTS WITH ADVANCED METASTATIC MELANOMA by Shah, J., Forero, A., Carlisle, R., Triozzi, P., LoBuglio, A., Kuwabara, T., Teitelbaum, A., Fujimori, M., Conry, M.

    Published in Journal of investigative medicine (01-01-2006)
    “…BackgroundCurrent therapeutic options for metastatic melanoma are limited. KW-2871 is an IgG1 kappa chimeric monoclonal antibody targeting ganglioside antigen…”
    Get full text
    Journal Article